Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized microglial immune cells that the companies plan to use toward revealing significant new targets in neurodegenerative diseases. The post Recursion, Roche Unveil Microglia Map of Neuro Disease Targets appeared first on GEN - Genetic Engineering and Biotechnology News.| GEN – Genetic Engineering and Biotechnology News
Electra Therapeutics has completed an oversubscribed $183 million Series C financing it said will fund a global pivotal trial of its lead pipeline candidate, a frontline treatment for secondary hemophagocytic lymphohistiocytosis (sHLH).| GEN - Genetic Engineering and Biotechnology News
